Abivax Market Capitalization from 2010 to 2025

ABVX Stock   7.50  0.01  0.13%   
Abivax SA Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 196.4 M in 2025.
Check Abivax SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abivax SA's main balance sheet or income statement drivers, such as Depreciation And Amortization of 853.7 K, Interest Expense of 19.1 M or Selling General Administrative of 24.8 M, as well as many indicators such as Price To Sales Ratio of 78.25, Dividend Yield of 0.0 or PTB Ratio of 1.84. Abivax financial statements analysis is a perfect complement when working with Abivax SA Valuation or Volatility modules.
  
Check out the analysis of Abivax SA Correlation against competitors.

Latest Abivax SA's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Abivax SA American over the last few years. It is Abivax SA's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abivax SA's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 649.94 M10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Abivax Market Capitalization Regression Statistics

Arithmetic Mean216,810,727
Geometric Mean179,309,205
Coefficient Of Variation66.64
Mean Deviation120,587,418
Median136,596,218
Standard Deviation144,477,142
Sample Variance20873.6T
Range431.4M
R-Value0.59
Mean Square Error14705T
R-Squared0.34
Significance0.02
Slope17,759,364
Total Sum of Squares313104.7T

Abivax Market Capitalization History

2025196.4 M
2024380.6 M
2023422.9 M
2022137.8 M
2021478.4 M
2020492.2 M
2019274.7 M

About Abivax SA Financial Statements

Abivax SA investors use historical fundamental indicators, such as Abivax SA's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Abivax SA. Please read more on our technical analysis and fundamental analysis pages.
Abivax SA is entity of United States. It is traded as Stock on NASDAQ exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.